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Conceptual, epidemiological and methodological 
design aspects for the study of pre-eclampsia
Aspectos de diseño conceptual, epidemiológicas y 
metodológicas para el estudio de la preeclampsia
Dear Editor:
We read with high interest the article by Alzate et al.1, (http://www.
ncbi.nlm.nih.gov/pmc/articles/PMC4732504/) and hereby we 
share comments about its design, study population and statistical 
approach along with revisiting some key concepts of the disease.
The prevalence of preeclampsia in Colombia is 4.5%2 and a case-
control study is appropriate to investigate risk and protective 
factors associated in such setting and their corresponding Odds 
Ratios. However, in the population studied by Alzate et al, the 
proportion of preeclampsia is 10% (387/3866 ). Under this 
scenario, a retrospective cohort study design is also appropriate 
and allows for direct estimation of incidences and relative risks 
could also be considered with direct estimates of relative risk. 
The exposure under study here (calcium prescription) is easy to 
measure from medical or administrative records or electronic files, 
therefore its comprehensive assessment in the whole population 
is feasible, cheap and easy to detect. Case-control studies are 
usually recommended when these requirements are not met for 
the exposure variable.
The study data was collected from two time periods. Consequently, 
we do not know what could have possibly changed during these 
years, as well as the difference in such changes between these 
two time periods, in the study population or in other contextual 
factors (health care quality, health system, regulations, physician’s 
attitudes, medication prescription, blood pressure approaches, 
etc.) and how they effect on the outcome (preeclampsia) and its 
determinants (the way prescriptions are registered and recordered 
could even change over time). There is no assurance regarding the 
data was collected by the same team or under the same standards. 
This can introduce severe biases due to unmeasured confounders 
in both time periods. A stratified analysis for each time period can 
help in this regards at least partially. 
In regards to its pathophysiology and management, one of the 
suggested interventions is calcium supplementation. AT least 
one systematic review establishes the protective effect of calcium 
occurs at doses greater than 1g/d of elemental calcium4. However, 
Alzate et al refer to studies5,6 that administered 600 mg/d of 
elemental calcium and 450mg/d of linoleic acid in a population of 
women with high risk for preeclampsia on whom calcium dosage 
was performed to confirm the depletion of calcium before starting 
the suplementation. Alzate et al do not report such values or even 
if such dosage was performed. If this calcium depletion exists, 
then there is a physiological and biological plausibility grounds to 
attribute the positive protective effect of calcium administered. The 
study population belongs to the Colombian Social Security System 
and is likely to not have severe calcium deficiency. This is a key 
consideration since the effectiveness of calcium supplementation 
is reported in women with a pre-pregnancy deficit, so the recovery 
of calcium reservoirs prevents the development of preeclampsia7.
In the statistical section we consider appropriate to take into account 
the variable “age” because it was different between cases and controls. 
However, the stratification by age is not the right approach. The 
reasons for this is the reduction of the sample size which leads to small 
numbers in specific cells and lead us to an OR of 0.0. Table 3 shows 
that none of the patients supplemented with CC+ALC developed 
preeclampsia and perhaps this is due to the stratification. A better 
approach is an age-adjusted multiple logistic regression to compute 
adjusted Odds Ratios as well as other confounders. 
Finally, the exposure variable was randomized in previous studies 
and the actual adherence to treatment was verified by close 
monitoring in each prenatal visit, questionnaires, and counting 
pills left in the medication container. These methods are the 
best to assess adherence to supplementation during pregnancy8. 
This was not done by Alzate et al and questions whether the 
CC+ALC combination really was what prevented preeclampsia in 
these pregnant women. If it is not possible to measure the actual 
implementation (calcium intake) then we cannot assess in a valid 
and reliable way its effectiveness. 
In general, research about preeclampsia is important in order 
to better understand and manage this disease. However, we also 
believe all conceptual, epidemiological and methodological 
aspects must rigorously be taken into account in order to obtain 
reliable valid and generalizable results. 
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